default author photo

Nicky Gilroy

The University of Sydney - Westmead Hospital

Hawkesbury Rd & Darcy Road

Westmead NSW 2145

Australia

SCHOLARLY PAPERS

2

DOWNLOADS

174

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Long-Term Persistence of Neutralizing Memory B Cells in SARS-CoV-2

Number of pages: 35 Posted: 25 Nov 2020
University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, Garvan Institute of Medical Research, Garvan Institute of Medical Research, Garvan Institute of Medical Research, University of Adelaide - Viral Immunology Group, Government of New South Wales - Virology Research Laboratory, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, The University of Sydney - School of Medical Sciences, Northern Beaches Hospital, University of New South Wales (UNSW) - Prince of Wales Clinical School, Royal North Shore Hospital, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, University of New South Wales (UNSW) - Kirby Institute, The University of Sydney - School of Medical Sciences, The University of Sydney - School of Medical Sciences, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute and Independent
Downloads 110 (640,165)

Abstract:

Loading...

SARS-CoV-2, neutralising antibodies, RBD, memory B cells

2.

Maintenance of Broad Neutralising Antibodies and Memory B Cells 12 Months Post-Infection Is Predicted by SARS-CoV-2 Specific CD4+ T Cell Responses

Number of pages: 54 Posted: 09 Sep 2021
University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, Garvan Institute of Medical Research, Garvan Institute of Medical Research, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - The Kirby Institute, University of Adelaide - Viral Immunology Group, Government of New South Wales - Virology Research Laboratory, University of New South Wales (UNSW) - Kirby Institute, affiliation not provided to SSRN, University of New South Wales (UNSW) - Kirby Institute, Northern Beaches Hospital, University of New South Wales (UNSW) - Prince of Wales Clinical School, Royal North Shore Hospital, The University of Sydney - Westmead Hospital, St George Hospital, Western Sydney University, The University of Sydney - Westmead Hospital, The University of Sydney, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute and University of New South Wales (UNSW) - Kirby Institute
Downloads 64 (924,743)

Abstract:

Loading...

SARS-CoV-2, 12 months after SARS-CoV-2 infection, RBD-specific memory B cells, protection efficacy prediction, SARS-CoV-2 antibodies, SARS-CoV-2 neutralisation, variants of concern, Delta variant